SBWire

HUDSON, MA (Feb. 21, 2023) – Precision Coating, a leading medical coatings service provider to interventional, orthopedic, and advanced surgical markets is proud to announce that it has recently achieved ISO 14001:2015 certification for its environmental management system at their Hudson, MA facility. Bill Ellerkamp, president of Precision Coating, commented that "this certification reflects a lot of hard work by our employees and a tremendous commitment to sustainability. Having a robust and certified environmental management system in place supports and reinforces our conviction to implement best practices to meet or exceed the expectations of all of our stakeholders. This milestone marks the completion of one stage of a long journey on which we will continue to do the right thing always and be relentless about improvement."

South Shore Based Digital Media Publisher Partners with Nation’s Largest Public Ice Rink Operator 

Global Market Direct's pharmaceuticals report, "Takeda Pharmaceuticals International GmbH - Product Pipeline Review - 2012" provides data on the Takeda Pharmaceuticals International GmbH's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Markets Direct's, 'Klebsiella Infections - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Klebsiella Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Klebsiella Infections. Klebsiella Infections - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Head And Neck Cancer Squamous Cell Carcinoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Head And Neck Cancer Squamous Cell Carcinoma. Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Abscess - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Abscess, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Abscess. Abscess - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Exanthema - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Exanthema, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Exanthema. Exanthema - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Cervical Dysplasia - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Cervical Dysplasia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cervical Dysplasia. Cervical Dysplasia - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Vaginal Atrophy (Atrophic Vaginitis), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Vaginal Atrophy (Atrophic Vaginitis). Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

A number of pressing challenges are facing Brazil's economy over the next few years, informing our view that the country is in for a period of lower-trend growth. We highlight slowing private consumption and the end of China's investment boom as major contributors to Brazil's medium-term growth trajectory.

BMI View: We have revised up again our forecast for corn production in 2011/12 on the back of strong yields for the country's second crop. We are slightly below consensus in our outlook for the soybean crop in 2012/13, as we believe a weaker-than-expected El Nino will present some downside risks to production. For sugar, our view for the harvest to pick up more strongly once weather concerns disappeared has played out very well, and we maintain our forecast for a recovery in output over the medium term. For livestock and dairy, we continue to see problems linked to heavy debt levels for the main companies in the sector, but we expect strong sales growth potential over our forecast period. For coffee, we expect exports to improve significantly in the coming months now that farmers have partially replenished stocks and that the latest estimates for the arabica crop this year are strong.

GlobalData's report, Ammonia Industry Outlook in Italy to 2016 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-depth coverage of Italy Ammonia industry. The research presents major market trends affecting the Ammonia industry in Italy. The report covers Italy Ammonia plants and presents installed capacity by process and technology. In addition, it presents Ammonia demand and production forecasts, end use demand forecasts, price trends, trade balance data and company shares of the major Ammonia producers in Italy. Overall, the report presents a comprehensive coverage of Italy Ammonia industry including all the major parameters.

GlobalData's new report, "France Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery" provides key market data on the France Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories - Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

GBI Research, a leading business intelligence provider, has released its latest research, "Women's Health Therapeutics Market to 2018 - Unmet Need for Safe and Effective Treatments due to Unfavorable Risk/Benefit Profile Associated with Hormone Replacement Therapy", which provides insights into the women's health therapeutics market until 2018. The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research's team of industry experts. It provides an in-depth analysis of the major diseases, and includes coverage of menopause, postmenopausal osteoporosis, endometriosis, infertility, and female contraceptives. The report provides in-depth analysis of the drivers and barriers that affect the global women's health market, and analyzes the markets for women's health disorders in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain), and Japan. The report also analyzes the women's health therapeutics market in India, China and Australia. Furthermore, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that have shaped the global market.

Antidepressants Market to 2018 - Despite Safety Concerns, Selective Serotonin Re-uptake Inhibitors (SSRIs) Continue to Dominate in the Absence of Effective Therapeutic Alternatives

GBI Research's new report, "LED and LED Driver IC Markets to 2016 - Government Incentives and Subsidies Drive Growth in Asia-Pacific, While Demand for Energy Efficient Lighting Drives the Global Market", analyzes key information on market opportunities in the Light Emitting Diode (LED) and LED driver Integrated Circuit (IC) markets. The report provides information on industry dynamics, key suppliers, and the sales revenue and sales volume of LEDs and LED driver ICs. The report also provides forecasts for LEDs based on product type, region and end-application until 2016. Market size forecasts until 2016 are provided for organic and inorganic LEDs. The mobile appliance, automotive, lighting, and signs/displays application markets for LEDs are also discussed.

GlobalData's clinical trial report, "Left Ventricular Hypertrophy Global Clinical Trials Review, H2, 2012" provides data on the Left Ventricular Hypertrophy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Left Ventricular Hypertrophy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Left Ventricular Hypertrophy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's new report, "Russian Federation Dental Devices Market Outlook to 2018 - CAD/CAM Dental Systems, Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others" provides key market data on the Russian Federation Dental Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories - CAD/CAM Dental Systems, Crowns and Bridges, Dental Biomaterials, Dental Chairs and Equipment, Dental Implants, Dental Lasers and Dental Radiology Equipment. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

GlobalData's new report, "Italy Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others" provides key market data on the Italy Diagnostic Imaging market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 10 market categories - Angio Suites, Bone Densitometers, C-Arms, Computed Tomography Systems, Contrast Media Injectors, Mammography Equipment, MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems and X-ray Systems. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Kuwait. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relating to the supply/demand balance for each of the key sub-segments. It also provides information relating to the natural gas assets (gas fields, pipelines and LNG terminals) in Kuwait. The report compares the investment environment in Kuwait with other countries in the region. The profiles of the major companies operating in the natural gas sector in Kuwait together with the latest news and deals are also included in the report.

This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Kuwait. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relating to the supply/demand balance for each of the key sub-segments. It also provides information relating to the crude oil assets (oil fields, refineries, pipelines and storage terminals) in Kuwait. The report compares the investment environment in Kuwait with other countries in the region. The profiles of the major companies operating in the crude oil sector in Kuwait together with the latest news and deals are also included in the report.

The Bahrain Insurance Report considers the prospects for life and non-life insurers in the country. The latest results and comments indicate that 2011 was a highly challenging, but not universally disastrous, year for Bahrain's insurance sector. We calculate that premiums in the non-life segment contracted. This was partly the result of the Arab Spring in the first half of last year. It was also the consequence of a lacklustre economic environment (and the slump in the real estate and construction sectors). Further, price competition in what is, by any standard, a small and fragmented segment has been fairly intense. If this were not enough, some companies experienced increased claims because of damage relating to the unrest or other problems. Reports published by Bahrain National Holdings and other local operators suggest the problems persisted through to H112.

Danone, Nestle and PepsiCo seem to be busy fighting for market share in packaged foods, and their soft drinks business enjoy limited resources. TCCC has a focused soft drinks business and it appears to be stronger in marketing and building its core brands than PepsiCo. The market has seen boutique style acquisitions continue, as there is a lack of large candidates in developed markets. Emerging markets such as the Middle East and Africa continue to offer long-term growth potential.

The review period saw slow growth overall for pet care in constant value terms, while strong current value growth was mainly linked to high inflation. Growth during the review period as a whole was mainly driven by the expatriate population in Egypt, with these consumers being more likely to keep animals as pets and also more likely to purchase pet care. However, there was also growing interest among Egypt's mid- and high-income consumers, with this linked to westernisation trends.

Consumers have become more aware of their impact on the environment and there is a growing trend of changing their lifestyles to reduce their carbon footprint. Therefore, the average in-store consumer will view a product's packaging as the most important factor to consider, before purchasing the product. With this in mind, an important trend in packaging is sustainability and the use of sustainable materials which are cost-effective but appeal to the consumer's ethics and ecological concerns.

The high level of commercial success experienced by the key companies in the cancer therapy market makes the market extremely attractive to drug developers. Treatment of cancer has shifted toward a more focused attack on the disease with targeted therapies. However, austerity packages imposed could see slower commercial growth and larger generic erosion of key brands.

This report provides the latest asset allocations of Indonesian HNWIs across 13 asset classes. The report also includes projections of the volume, wealth and asset allocation of Indonesian HNWIs to 2016 and a comprehensive and robust background of the local economy.